Sindermann; Herbert

Patent Applications and Registrations

Patent applications and USPTO patent grants for Sindermann; Herbert.The latest application filed is for "use of alkylphosphocholines in combination with antimetabolites for the treatment of benign and malignant oncoses in humans and mammals".

Company Profile

0.9.4

Sindermann; Herbert - Norden-Norddeich DE
Sindermann; Herbert - Rodgau DE

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Method of assessing growth hormone deficiency in humans by a macimorelin containing composition Grant 10,288,629 - Ammer , et al.	2019-05-14
Use of perifosine in combination with antimetabolites for the treatment of benign and malignant oncoses in humans and mammals Grant 8,551,977 - Engel , et al. October 8, 2	2013-10-08
Use of perifosine in combination with antimetabolites for the treatment of benign and malignant oncoses in humans and mammals Grant 8,507,710 - Engel , et al. August 13, 2	2013-08-13
Use of alkylphosphocholines in combination with antitumor medications for the treatment of benign and malignant oncoses in humans and mammals Grant 8,389,497 - Engel , et al. March 5, 2	2013-03-05
Use of alkylphosphocholines in combination with antimetabolites for the treatment of benign and malignant oncoses in humans and mammals Grant 8,383,605 - Engel , et al. February 26, 2	2013-02-26
Use of alkylphosphocholines in combination with antimetabolites for the treatment of benign and malignant oncoses in humans and mammals App 20110028421 - Engel; Jurgen ; et al.	2011-02-03
Use of Alkylphophocholine in Combination with Antitumor Medication for the Treatment of Benign and Malignant Oncoses in Humans and Mammals App 20100189784 - Engel; Jurgen ; et al.	2010-07-29
Use of Aalkylphophocholines in Combination with Antitumor Medication for the Treatment of Benign and Melignant Oncoses in Humans and Mammals App 20100190738 - Engel; Jurgen ; et al.	2010-07-29
Use of alkylphosphocholines in combination with antitumor medications for the treatment of benign and malignant oncoses in humans and mammals App 20040097470 - Engel, Jurgen ; et al.	2004-05-20

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.